Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Tremfya (guselkumab) and Humira (adalimumab) are both injectable medications used to treat autoimmune conditions, but they have some key differences. Tremfya is a monoclonal antibody that targets interleukin-23 (IL-23) to reduce inflammation and is specifically approved for moderate-to-severe plaque psoriasis and active psoriatic arthritis. On the other hand, Humira is a biologic disease-modifying antirheumatic drug (DMARD) that blocks tumor necrosis factor (TNF) and is approved for a wider range of conditions, including rheumatoid arthritis, Crohn's disease, and ulcerative colitis, among others. Tremfya is typically injected every 8 weeks after initial doses, while Humira is usually injected every other week. Tremfya is only available as a brand-name medication, making it potentially more expensive, whereas Humira has several biosimilars available. Both medications can increase the risk of infections, but Humira also carries warnings for potential risks of certain cancers and heart failure.
Tremfya (guselkumab)
Humira (adalimumab)
Tremfya (guselkumab)
Humira (adalimumab)
Summary of Tremfya vs. Humira
Summary for Interleukin antagonist
Prescription only
Tremfya (guselkumab) is an injection for adults with certain inflammatory conditions. It helps treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Tremfya (guselkumab) is a monoclonal antibody known as an interleukin antagonist. It calms your immune system to lower inflammation. The dosing schedule is every 1 or 2 months, depending on your condition and how far along you are in treatment. Side effects are upper respiratory infections, headache, and injection site reactions. There's also a risk of other infections and liver problems as long-term side effects.
Summary for Biologic DMARD
Prescription only
Humira (adalimumab) is an injectable medication used for treating many different autoimmune conditions, including rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis. It's usually given every other week, and it can be used alone or taken with methotrexate or other non-biologic medications. This medication is available as many different brands (or biosimilars).